| Aflatoxin* | Hepatic size enlargement | Increase in coagulation time |
| Increase in proto-combining time | Corporal size reduction | |
| Pro-ventricle size enlargement | Gizzard size enlargement | |
| Laying reduction | Testicle atrophia | |
| Embryo development delay | Embryo malformations | |
| Sericeous protein reduction | Antibody absorption reduction | |
| Ochratoxin A* | Kidney weight increase | Corporal Weight loss |
| Increased Urate deposits | Sexual maturity delay | |
| biliary conducts multiplication | Laying reduction | |
| Immunization defenses reduction | ||
| Rubratoxin B* | Hepatic hypertrophy | Fabricius bag Atrophia |
| Embryo malformation | ||
| Diacetoxycirpernol* | Lymphatic tissue necropsy | Spinal cord necropsy |
| Biliary vesicle necropsy | ||
| T-2* | Mouth necropsy | Hepatic hypertrophy |
| VII factor and proto-combining reduction | Subcutaneous edema | |
| Zearalenone* | Liver weight increase | |
| Kidney weight increase | Heart weight increase | |
| Testicle intestinal fibrosis | Estrogenic effect | |
| Testicle weight reduction | Crest size reduction | |
| Citrinin* | Renal size enlargement | Increase in water Consumption |
| Urine production increase | ||
| Penicilloic* Acid Sterigmata-cystine | Heart muscle alteration | Renal necropsy |
| Hepatic necropsy | ||
| Penitrem A and B* | Neurotoxic | |
| Patulin | Hepatic alteration |
SWINE CLINICAL MYCOTOXICOSIS
(OSWEILER, 1992)
|
Toxin |
Category |
Clinical Effect |
|
Aflatoxin |
Development / grow-out |
* Growth
and feed conversion reduction. |
|
Sow / Reproductive Stage |
* No conception effect, normal slow growing suckling pigs because of aflatoxin in the milk. |
|
|
Ochratoxin and Citrinin |
Grow-out
|
* Moderate
renal lesions. reduction in weight gain. |
|
Sows / Reproductive Stage |
* Normal when they eat on the first month |
|
|
Tricotecen T-2 and DAS |
Development /Grow-out |
* Reduced
feed consumption, oral and dermal irritation. |
|
Deoxynivalenol |
* Reduced
feed consumption. |
|
|
Zearalenone F-2 |
Reproductive Sows |
* vulvovaginitis, Prolapse |
|
Cycling sows |
* Persistency
of anestra lutea body. |
|
|
Pregnant sows |
* Early
embryo mortality when feeding |
|
|
Fumonisin |
Swine |
* Acute lung edema, hepatitis, lymphoblasts genesis paralysis, reduced feed consumption |
VARIOUS
MYCOTOXINS BIOCHEMICAL EFFECTS
(SHULLY
CHEEKE, 1983)
|
SYSTEM |
MYCOTOXINS |
|
* Metabolic System: |
|
|
- Carbohydrates metabolism |
Aflatoxin, Ochratoxin A, Phomopsin A |
|
- Lipids metabolism |
Aflatoxin, Ochratoxin A, T-2, Citrinin, Rubratoxin B |
|
- Vitamin assimilation |
Aflatoxin, dicumarol |
|
- Protein synthesis |
Aflatoxin, Trichothecenes |
|
- Mitochondrial respiration |
Aflatoxin, Ochratoxin A, Rubratoxin B, Patulin |
|
* Endocrine system |
Aflatoxin, Zearalenone, Ergot, Alkaloids |
|
* Skeletal system |
Aflatoxin, Ochratoxin A |
Note: The combination of two or more mycotoxins, even at LOW levels can be more toxic than one toxin at a high level and might NOT show the same symptoms as one mycotoxin.
Who has the last word on the efficacy of a mycotoxin adsorbent?
The animal is the one that proves the efficacy.
You can compare
MYCO-AD® VS ANY PRODUCT
The animal will show you the difference.
MYCO-AD®
The most conclusive solution to mycotoxin problems.
| < PREVIOUS SECTION |
|
NEXT
SECTION >
|